Ynecologic Malignancy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ynecologic Malignancy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ynecologic Malignancy Today - Breaking & Trending Today

Zentalis Pharmaceuticals Inc (ZNTL) Reports Q3 2023 Financial Results and Operational Updates

Published: November 7, 2023

Company on track for first NDA submission in a gynecologic malignancy in 2026 with a cash balance of $517 million

Source: yahoo.com

Related Topics:

Mark LacknerZentalis Pharmaceuticals IncCompany Performance AnalysisCompany PerformanceChief Translational OfficerKevin BunkerChief ScientificBalance SheetCash Flow StatementNew Drug ApplicationBiomarker StrategyChief Scientific OfficerYnecologic MalignancyCash BalanceKevin BunkerCash EquivalentsIopharmaceutical CompanyNda SubmissionChief Scientific Officer